Search Form
First, enter a politician or zip code
Now, choose a category
 

Amy Klobuchar's Public Statements on Issue: Drugs

Office: U.S. Senate (MN) - Sr, Democratic
Date Title
April 20, 2018 Klobuchar, Collins Introduce Legislation to Support Community Prevention and Treatment Efforts for Low-Income Families Impacted by the Opioid Epidemic
April 18, 2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
April 13, 2018 Senators Collins, Klobuchar Introduce Bill to Authorize $50 Million Over Five Years for Community Organizations Responding to Opioid Addiction
April 12, 2018 Klobuchar Highlights Efforts to Address the Dangers of Synthetic Drugs like Fentanyl at Judiciary Subcommittee Hearing
March 23, 2018 Klobuchar Announces Congress Passes Major Funding to Combat the Opioid Epidemic
March 8, 2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
March 5, 2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
Feb. 27, 2018 Portman, Whitehouse, Capito, Klobuchar, Sullivan, Hassan, Cassidy & Cantwell Introduce CARA 2.0 Act
Feb. 22, 2018 Letter to Mr. Sundar Pichai, CEO, Google, Mr. Satya Nadella, CEO, Microsoft, Mr. Ben Silbermann, CEO and Co-Founder, Pinterest, and Ms. Mayer, CEO of Yahoo - Clamp Down on Illegal Online Drug Sales and Advertising
Feb. 15, 2018 Brown, Cornyn, Feinstein, Nelson, Klobuchar, Portman, Tillis, Ratcliffe, Rice Introduce Bill to Combat Drug-Facilitated Human Trafficking
Dec. 1, 2017 Klobuchar Statement on Minnesota Lawsuits Against Opioid Drug Manufacturers and Distributors
Nov. 8, 2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
Nov. 7, 2017 Letter to Mr. Brenton L. Saunders, CEO, Allergan plc - Monopoly Keeps Price of Drug High, Limits Competition
Nov. 3, 2017 Letter to the Hon. Donald J. Trump, President - Support Funding to Stem Opioid Epidemic
Nov. 1, 2017 President's Commission on Combating Drug Addiction and the Opioid Crisis Includes Bipartisan Klobuchar Bills in Recommendations to the Administration
Oct. 26, 2017 Klobuchar Statement on Declaration of the Opioid Epidemic as a Public Health Emergency
Oct. 25, 2017 Letter to President Donald Trump - Senators Call on President to Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
Oct. 25, 2017 Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone
Oct. 20, 2017 Letter to Eric Hargan, Acting Secretary of Health and Human Services, Robert Patterson, Acting Administrator of Drug Enforcement Administration - Ensuring Patient Access and Effective Drug Enforcement Act
Oct. 10, 2017 Klobuchar Statement on Reports of K2 Synthetic Drug Overdoses
Sept. 8, 2017 Klobuchar Statement on Report Showing Drug Overdose Deaths on the Rise in Minnesota
July 19, 2017 Letter to Richard Baum, Acting Director Office of National Drug Control Policy - Deliver a Strategy to Battle Opioid Addiction
July 11, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
July 7, 2017 Klobuchar Statement on Reports of Decline in Rate of Opioid Prescribing
July 3, 2017 Klobuchar Presses Three Pharmaceutical Companies for Action on High Insulin Prices; Urges Vigilance Against Anticompetitive Conduct
June 26, 2017 Klobuchar, Portman Call on the DEA to Provide Information to Support First Responders on the Frontlines in the Fight Against Synthetic Opioids
June 26, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Call on the DEA to Provide Information to Support First Responders on the Frontlines in the Fight Against Synthetic Opioids
June 22, 2017 Klobuchar, Bipartisan Group of Members of Senate Judiciary Committee Urge FDA Commissioner to Address Abuses in the Regulatory Process that Delay Competition and Increase Prescription Drug Costs
May 24, 2017 Letter to the Hon. Donald J. Trump, President - Delay Visit of Filipino Leader, Denounce Human Rights Abuses
May 17, 2017 Pro-Consumer Groups Announce Endorsement of Klobuchar's Legislation to Lower Prescription Drug Prices for Seniors
May 15, 2017 Klobuchar, McCain, Grassley Urge OMB Director Mulvaney to Use Existing Executive Authority to Bring Down Prescription Drug Costs
May 9, 2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Fully Fund Office of National Drug Control Policy
April 28, 2017 Klobuchar Outlines Minnesota Priorities for Federal Funds to Combat Opioid Crisis Ahead of National Take-Back Day
April 27, 2017 Klobuchar, Leaders of Senate and House Judiciary Committees Introduce Bipartisan Legislation to Counter Rising Prescription Drug Prices
April 20, 2017 Klobuchar Announces $5 Million in Federal Funding to Combat Opioid Addiction in Minnesota
April 11, 2017 Letter to the Hon. Donald Trump, President - Help Fight Opiod Epidemic
April 4, 2017 Rep. Jenkins Introduces Bill to Help Combat Opioid Abuse
March 31, 2017 With New Lethal Strain of Synthetic Heroin From China Causing Overdose Deaths in Minnesota, Klobuchar Renews Call for Passage of Her Bipartisan Bill to Crack Down on Synthetic Opioids from Overseas
March 30, 2017 Klobuchar, Portman Introduce Legislation to Require Use of Prescription Drug Monitoring Programs Before Prescribing Powerful Painkillers
March 30, 2017 Portman, Klobuchar Introduce Legislation to Require Use of Prescription Drug Monitoring Programs Before Prescribing Powerful Painkillers
March 29, 2017 Pro-Consumer Groups Back Klobuchar's Bipartisan Legislation to Crack Down on Anti-Competitive Pay-for-Delay Pharmaceutical Deals
March 29, 2017 As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices
March 21, 2017 Letter to the Hon. Mitch McConnell - Regarding Opioid Crisis
March 8, 2017 Letter to the Hon. Rex Tillerson, Secretary of State - Work with United Nations to Take Action on Illicit Fentanyl
March 8, 2017 Klobuchar and Bipartisan Group of Senators Introduce Legislation to Save and Protect Recovering Opioid Addicts
March 3, 2017 Senators Re-Introduce LifeBOAT Act
Feb. 21, 2017 CNN - Stop trafficking of synthetic heroin through the mail
Feb. 17, 2017 Letter to the Hon. Jean-Claude Junker, President of the European Commission - European Union Support to Combat the Fentanyl Crisis
Feb. 14, 2017 Letter to the Honorable Tom Price, Secretary of Health and Human Services - Permit Safe Importation of Prescription Drugs from Canada
Feb. 14, 2017 Portman, Klobuchar, Rubio, Hassan Introduce Legislation to Address Overdose Spike From Synthetic Opioids
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top